Human CD56bright NK Cells: An Update
Open Access
- 1 April 2016
- journal article
- review article
- Published by The American Association of Immunologists
- Vol. 196 (7), 2923-2931
- https://doi.org/10.4049/jimmunol.1502570
Abstract
Human NK cells can be subdivided into various subsets based on the relative expression of CD16 and CD56. In particular, CD56brightCD16−/dim NK cells are the focus of interest. They are considered efficient cytokine producers endowed with immunoregulatory properties, but they can also become cytotoxic upon appropriate activation. These cells were shown to play a role in different disease states, such as cancer, autoimmunity, neuroinflammation, and infection. Although their phenotype and functional properties are well known and have been extensively studied, their lineage relationship with other NK cell subsets is not fully defined, nor is their precise hematopoietic origin. In this article, we summarize recent studies about CD56bright NK cells in health and disease and briefly discuss the current controversies surrounding them.Keywords
This publication has 101 references indexed in Scilit:
- Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumorsNature Medicine, 2011
- Circulating CD56+ cells of diabetic women show deviated homing potential for specific tissues during and following pregnancyHuman Reproduction, 2011
- CD34+hematopoietic precursors are present in human decidua and differentiate into natural killer cells upon interaction with stromal cellsProceedings of the National Academy of Sciences, 2011
- Interleukin‐2/interleukin‐2 antibody therapy induces target organ natural killer cells that inhibit central nervous system inflammationAnnals of Neurology, 2010
- Central nervous system (CNS)–resident natural killer cells suppress Th17 responses and CNS autoimmune pathologyThe Journal of Experimental Medicine, 2010
- Perturbation of the natural killer cell compartment during primary human immunodeficiency virus 1 infection primarily involving the CD56bright subsetImmunology, 2010
- Natural killer cells trigger osteoclastogenesis and bone destruction in arthritisProceedings of the National Academy of Sciences, 2009
- CD56bright natural killer (NK) cells: an important NK cell subsetImmunology, 2009
- Increased proportion of CD56bright natural killer cells in active and inactive systemic lupus erythematosusImmunology, 2008
- Immunoregulatory factors in multiple sclerosis patients during and after pregnancy: relevance of natural killer cellsClinical and Experimental Immunology, 2007